Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
Condition(s):Weight GainLast Updated:April 20, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Weight GainLast Updated:April 20, 2018Completed
Condition(s):Human Immunodeficiency Virus Infection; Diabetes MellitusLast Updated:March 10, 2017Terminated
Condition(s):ObesityLast Updated:September 12, 2014Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:April 9, 2015Completed
Condition(s):Polycystic Ovary Syndrome; Overweight and Obesity; Disorder of Glucose RegulationLast Updated:September 11, 2019Completed
Condition(s):Pre DiabetesLast Updated:October 28, 2022Completed
Condition(s):Hypothalamic Obesity; Diabetes MellitusLast Updated:October 22, 2013Unknown status
Condition(s):Septic Shock; Inflammation; Glucose Homeostasis; Organ Dysfunction; Health-related Quality of LifeLast Updated:October 5, 2017Withdrawn
Condition(s):Type 2 Diabetes MellitusLast Updated:February 24, 2015Completed
Condition(s):Diabetes Mellitus, Type 2; Heart Failure, DiastolicLast Updated:September 4, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.